BioMarin Pharmaceutical (Nasdaq: BMRN) develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Recent Mentions on Fool.com
- Why 1 Wall Street Firm Thinks BioMarin Pharmaceutical Inc. Could Soar
- Healthcare Merger Monday: These 3 Stocks Could Be Healthcare's Next Buyout Targets
- Why BioMarin Pharmaceutical Inc. Stock Is Surging Today
- Did Researchers Just Discover a Functional Cure for Duchenne Muscular Dystrophy?
- "Profitability" in Sight for BioMarin Pharmaceutical Inc.